- Home
- DRTS vs NCZ Comparison
DRTS vs NCZ Comparison
Compare DRTS & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- NCZ
- Stock Information
- Founded
- DRTS 2015
- NCZ 2003
- Country
- DRTS Israel
- NCZ United States
- Employees
- DRTS N/A
- NCZ N/A
- Industry
- DRTS Medical/Dental Instruments
- NCZ Finance Companies
- Sector
- DRTS Health Care
- NCZ Finance
- Exchange
- DRTS Nasdaq
- NCZ Nasdaq
- Market Cap
- DRTS 211.7M
- NCZ 248.9M
- IPO Year
- DRTS N/A
- NCZ N/A
- Fundamental
- Price
- DRTS $2.62
- NCZ $11.51
- Analyst Decision
- DRTS Strong Buy
- NCZ
- Analyst Count
- DRTS 2
- NCZ 0
- Target Price
- DRTS $8.00
- NCZ N/A
- AVG Volume (30 Days)
- DRTS 68.0K
- NCZ 533.0K
- Earning Date
- DRTS 03-12-2025
- NCZ 01-01-0001
- Dividend Yield
- DRTS N/A
- NCZ 12.16%
- EPS Growth
- DRTS N/A
- NCZ N/A
- EPS
- DRTS N/A
- NCZ N/A
- Revenue
- DRTS N/A
- NCZ N/A
- Revenue This Year
- DRTS N/A
- NCZ N/A
- Revenue Next Year
- DRTS N/A
- NCZ N/A
- P/E Ratio
- DRTS N/A
- NCZ N/A
- Revenue Growth
- DRTS N/A
- NCZ N/A
- 52 Week Low
- DRTS $1.75
- NCZ $2.50
- 52 Week High
- DRTS $4.39
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- DRTS 37.08
- NCZ 23.49
- Support Level
- DRTS $2.59
- NCZ $11.62
- Resistance Level
- DRTS $2.73
- NCZ $11.95
- Average True Range (ATR)
- DRTS 0.20
- NCZ 0.22
- MACD
- DRTS -0.01
- NCZ -0.08
- Stochastic Oscillator
- DRTS 23.53
- NCZ 6.56
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.